Framework agreement for medicines with the active substances clotrimazole and hydrocortisone

Summary

This tender concerns a framework agreement for medicines with the active substance clotrimazole + hydrocortisone. It is an open procedure intended to conclude medicine discount agreements with as many interested pharmaceutical companies as possible for the period 01/09/2026–31/08/2028, with a possible 12-month extension. The company should check the tender documents for the exact participation and bid submission requirements.